Ottawa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The global automated pharmacy compounding systems market size is calculated at USD 3.12 billion in 2026 and is expected to reach around USD 5.27 billion by 2035, growing at a CAGR of 5.98% for the forecasted period. The growth of the market is driven by factors like the need to reduce medication errors, the demand for personalised medicine, and stringent regulatory standards.
How Did North America Dominate the Automated Pharmacy Compounding Systems Market in 2024?
North America held a major share of 40% of the market in 2024. The North American market for automated pharmacy compounding systems is experiencing robust growth, this growth is driven by factors like the demand for accurate, customised medications, increased adoption of robotics in pharmacies, and the need to reduce errors in sterile and non-sterile drug preparation.
What Made the Asia Pacific Significantly Grow in The Automated Pharmacy Compounding Systems Market In 2024?
Asia Pacific is expected to grow at a 9.0% CAGR during the forecast period. The automated pharmacy compounding systems market in the Asia Pacific is experiencing rapid growth. This expansion is driven by the rising prevalence of chronic diseases, the increasing need to minimise medication errors, and the greater adoption of technology. China is a key market within the region, anticipated to register the highest CAGR, while countries like India, Japan, and Singapore also contribute significantly to this growth.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
Segmental Insights
By product,
The robotic compounding systems segment led with a 55% share of the automated pharmacy compounding systems market in 2024. Robotic compounding systems dominate the advanced pharmacy automation landscape, driven by their ability to deliver high-precision sterile preparations with minimal human intervention. Their adoption is growing in large hospital pharmacies and compounding centres where high throughput, safety, and standardisation are critical.
The automated liquid compounding systems segment is expected to be the fastest-growing at an 8.5% CAGR in the studied years. Automated liquid compounding systems are gaining traction as pharmacies increasingly prioritise workflow efficiency and consistency in liquid medication preparation. They are especially beneficial for pediatric, oncology, and TPN formulations where accurate liquid dosing is essential. Their simpler operational model also makes them more accessible for mid-sized pharmacy settings.
By technology,
The robotics-based systems segment held 60% revenue share of the market in 2024. Robotic-based systems represent the most technologically advanced segment, offering end-to-end automation with robotic arms, barcode-guided verification, and closed-system sterility protection. These systems are preferred in high-volume hospital compounding units due to their unmatched precision, reproducibility, and ability to handle hazardous drugs safely. Growing emphasis on staff safety and increased complexity of personalised medication are driving strong adoption of fully robotic technologies.
The semi-automated systems segment is expected to grow rapidly at an 8.0% CAGR during 2025-2034. Semi-automated systems remain relevant for facilities seeking improved accuracy and reduced workload without the high investment required for full robotic solutions. These systems combine automated dispensing or mixing capabilities with human oversight, making them suitable for smaller hospitals and outpatient pharmacies. Their flexibility and lower capital cost support steady demand, especially in emerging healthcare markets transitioning from manual compounding.
By end user,
The hospitals segment was dominant with a 50% revenue share of the market in 2024. Hospitals account for the largest share of automated pharmacy compounding system usage due to their high daily compounding volumes and the need to maintain sterile, accurate, and regulation-compliant medication preparation. Increasing prevalence of chronic diseases, rising demand for IV therapy, and stringent regulatory standards are pushing hospitals toward advanced compounding automation. Large tertiary care and oncology hospitals are particularly strong adopters.
The retail pharmacies segment is expected to grow at a rapid CAGR of 8.5% in the predicted timeframe. Retail pharmacies are gradually adopting automated compounding technologies as personalised medicine, speciality drug dispensing, and customised formulations gain prominence. While adoption is still lower compared to hospitals, retail chains and speciality pharmacies are investing in semi-automated and select robotic systems to increase service differentiation, reduce turnaround time, and ensure consistent quality. Growth in chronic therapy programs and home infusion services further supports demand from this segment.
Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting
Recent Developments
- In July 2025, Merck, a major science and technology company, introduced the AAW Automated Assay Workstation, a solution led by Opentrons, to automate routine laboratory experiments and minimise hands-on time with ensured consistency in results.
- In February 2025, South Korea-based Hanmi launched Countmate, a fully automated vial dispensing machine personalised to the unique preferences of the Canadian and US markets.
- In December 2024, Germfree, an innovator in modular and mobile cleanroom infrastructure, equipment, and services, launched Smarthood (trademarked) for IV medication preparation.
Browse More Insights of Towards Healthcare:
The global non-sterile compounding pharmacy market size is calculated at US$ 5.97 billion in 2024, grew to US$ 6.41 billion in 2025, and is projected to reach around US$ 12.11 billion by 2034. The market is expanding at a CAGR of 7.34% between 2025 and 2034.
The global compound management market size is calculated at US$ 492.14 million in 2024, grew to US$ 563.56 million in 2025, and is projected to reach around US$ 1899.41 million by 2034. The market is expanding at a CAGR of 14.51% between 2025 and 2034.
The compounded topical drug market was estimated at US$ 4.27 billion in 2023 and is projected to grow to US$ 6.78 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.29% from 2024 to 2034.
The global compounding pharmacy market size was estimated at US$ 13.19 billion in 2023 and is projected to grow to US$ 22.91 billion by 2034, rising at a compound annual growth rate (CAGR) of 5.15% from 2024 to 2034.
The global compounding chemotherapy market size is calculated at US$ 5.34 billion in 2024, grew to US$ 5.68 billion in 2025, and is projected to reach around US$ 9.97 billion by 2034. The market is expanding at a CAGR of 6.44% between 2025 and 2034.
The global GCC compounding pharmacy market size is calculated at USD 16.39 million in 2024, grew to USD 17.91 million in 2025, and is projected to reach around USD 40.26 million by 2034. The market is expanding at a CAGR of 9.27% between 2025 and 2034.
The U.S. compounding pharmacy market size in 2024 was US$ 6.57 billion, expected to grow to US$ 6.98 billion in 2025 and further to US$ 12.02 billion by 2034, backed by a robust CAGR of 6.24% between 2025 and 2034.
The global vials used in compounding pharmacy market is surging, with an overall revenue growth expectation of hundreds of millions of dollars during the forecast period from 2024 to 2034. Projected revenue growth is set to skyrocket while the market held a notable share in 2025.
The U.S. 503B compounding pharmacies market size was valued at US$ 1.25 billion in 2025 and is projected to grow to 1.35 billion in 2026. Forecasts suggest it will reach approximately US$ 2.61 billion by 2035, registering a CAGR of 7.63% during the period.
Automated Pharmacy Compounding Systems Market Key Players List
- Capsa Healthcare
- IMA Group
- ARxIUM
- Medimix Systems
- Cerner Corporation
- McKesson Corporation
- Cardinal Health
- Parata Systems
- Baxter International
- Yuyama Co., Ltd.
Segments Covered in The Report
By Product
- Robotic Compounding Systems
- Tablet & Capsule Dispensers
- Injectable Compounding Robots
- Automated Liquid Compounding Systems
- IV Admixture Systems
- Oral Liquid Compounding Systems
- Accessories & Software
- Barcode Scanners & Labeling Systems
- Compounding Software
By Technology
- Robotic-Based Systems
- Semi-Automated Systems
By End User
- Hospitals
- Clinics
- Retail Pharmacies
- Compounding Pharmacies
By Region
- North America
- U.S.
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/6385
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
